• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA PLATELET+SAMPLER, PLASMA, RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA PLATELET+SAMPLER, PLASMA, RBC SET Back to Search Results
Model Number 82446
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/11/2021
Event Type  malfunction  
Manufacturer Narrative
Lot number and expiry information are not available at this time.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported an increase in (b)(6) bac-t sample results.Donor unit #: (b)(6) the platelet collection is not available for return because it was discarded by the customer.There was not a transfusion recipient or patient involved at the time of the unit processing, therefore no patient information is reasonably known at the time of the event.
 
Event Description
The customer reported an increase in positive bac-t sample results.Donor unit #: w091021357755 the platelet collection is not available for return because it was discarded by the customer.There was not a transfusion recipient or patient involved at the time of the unit processing, therefore no patient information is reasonably known at the time of the event.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: bpa culture bottles are used with the bact/alert® microbial detection systems for quality control testing of platelets.Bact/alert bpa culture bottles support the growth of aerobic microorganisms (bacteria and fungi).Bpn culture bottles are used with the bact/alert® microbial detection systems for quality control testing of platelets.Bact/alert bpn culture bottles support the growth of anaerobic and facultative anaerobic microorganisms (bacteria).The 20 ml large volume bact samplers increase the volume of inoculum hence better detection of contaminated units with a low bacterial titer.An increase in positive tests is a possibility with enhanced sensitivity.Multiple attempts were made to obtain additional information including the disposable lot number, machine serial numbers, bacterial strains and status of the recipient who had been transfused with products allegedly contaminated with bacterial.The customer did not respond to any of the requests.Triple unit din w091021357755 had 4/6 initial positive samples.All of the platelet products associated with this din expired.The phenomenon of bacterial contamination in blood products, especially platelets, is known to occur.With current technologies, given the nature of microorganisms on human skin and the mechanical act of piercing the skin coupled with the fact that platelets must be incubated at room temperature it is not possible to eliminate this phenomenon from occurring.The devices terumo bct manufactures in lakewood / littleton, co, vietnam, costa rica and harmac to collect, separate and store blood products are terminally sterilized to an sal of < 1.0 x 10-6.Additionally, a sterility assurance system has been designed and employed to ensure this sal will be achieved for every product manufactured.Therefore, it may be concluded bacterial contamination observed in collected blood products from terumo bct devices is most likely due to the inherit hazard of collecting blood as it relates to bacterial contamination.The customer did not provide the disposable lot number.All lots must meet acceptance criteria for release.Root cause: a root cause assessment was performed for the microbial contamination with true positive and indeterminate results.Based on the available information a definitive root cause could not be determined but it is likely due to one or a combination of the possible causes listed below: * improper venipuncture technique introduces bacteria at access site resulting in bacterial growth in product bag.* inadequate or no blood diversion performed due to operator error resulting in bacterial contamination of product.* species was endogenous and originated from the donor.* inadequate post-processing laboratory practices such as qc sampling or handling techniques.A root cause assessment was performed for the microbial contamination with false positive results.Based on the available information, their qc lab had contaminated the bottles resulting in false positive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA PLATELET+SAMPLER, PLASMA, RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key12682389
MDR Text Key280510768
Report Number1722028-2021-00334
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583824461
UDI-Public05020583824461
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK190332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date 10/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number82446
Device Catalogue Number82446
Was Device Available for Evaluation? No
Date Manufacturer Received03/09/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-